Colgate Palmolive India reported a decline in first-quarter profit on Tuesday, as feeble urban demand and intensified ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $100.6, along with a high estimate of $108.00 and a low estimate of $87.00. This upward ...

Software platform DoubleVerify (DV) has announced that Colgate-Palmolive Australia has successfully leveraged DV’s pre-bid brand suitability controls to improve media quality across its video ...

Wall Street expects a year-over-year decline in earnings on higher revenues when Colgate-Palmolive (CL) reports results for the quarter ended June 2025. While this widely-known consensus outlook is ...

Palmolive's weak performance to continue in the near-term, with the mentioned challenges to persist in the second quarter as ...

Colgate-Palmolive Australia used Double Verify’s pre-bid brand suitability controls to significantly improve media quality in its video ad campaigns.The announcement:DoubleVerify (“DV”) (NYSE: DV), ...

Revenue from operations fell 4.3 percent to Rs 1,433 crore, with total income down from Rs 1,496.71 crore a year ago.

Results: Total expenses stood at ₹1,020.05 crore, marginally lower than ₹1,030.86 crore a year ago but up from ₹1,003.95 ...

Detailed price information for Colgate-Palmolive Company (CL-N) from The Globe and Mail including charting and trades.

The National Institute for the Protection of Consumer Rights (Pro Consumidor) and the General Directorate of Medicines, Food, ...

Colgate-Palmolive's forward PE ratio is 22.48 compared to Procter & Gamble's 18.84 and Unilever's 19.30, indicating that Colgate-Palmolive is over-priced relative to its peers.

Colgate-Palmolive’s (NYSE: CL) stock has gone from $67.42 in November 2016 to $66.52 in November 2019. Over this period there has been a ~3% rise in total revenue and an equal drop in number of ...